As of May 29, 2025, Targovax ASA (TRVX.OL) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Targovax ASA's Forward P/E to Peers
To better understand Targovax ASA's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Targovax ASA (TRVX.OL) | - |
| ReNeuron Group PLC (RENE.L) | 1820.39 |
| Arcticzymes Technologies ASA (AZT.OL) | 89.32 |
| Adocia SA (ADOC.PA) | 0.79 |
| Vaccibody AS (VACC.OL) | 0.18 |
Compared to its competitors, Targovax ASA's Forward P/E is difficult to compare due to insufficient data.